In vitro and in vivo activity of a novel oxamide-hydrazone hybrid derivative against triple-negative breast cancer - Tahmasvand, Raheleh; Dehghani, Soudeh; Kooshafar, Zahra; Emami Najafi, Seyedeh Azadeh; Almasirad, Ali; Salimi, Mona (Naunyn-Schmiedeberg's archives of pharmacology, 2024)
Keywords: Animal models; Animals; Antineoplastic Agents - chemical synthesis; Antineoplastic Agents - chemistry; Antineoplastic Agents - pharmacology; Apoptosis; Apoptosis - drug effects; Biomedical and Life Sciences; Biomedicine; Breast cancer; Caspase-3; Cell death; Cell Line, Tumor; Female; Flow cytometry; Humans; Hydrazones - chemical synthesis; Hydrazones - pharmacology; Hydrazones - therapeutic use; Immunohistochemistry; Ki-67 Antigen - metabolism; Membrane potential; Membrane Potential, Mitochondrial - drug effects; Mice; Mice, Inbred BALB C; Neurosciences; Pharmacology/Toxicology; Platelet Endothelial Cell Adhesion Molecule-1 - metabolism; Triple Negative Breast Neoplasms - drug therapy; Triple Negative Breast Neoplasms - pathology; Tumors; Western blotting; Mitochondria; Breast cancer; Anti-tumor; BALB/c; Apoptosis